Jan Lindberg - Chordate Medical CTO Mang

CMH Stock   12.55  0.25  1.95%   

Insider

Jan Lindberg is CTO Mang of Chordate Medical Holding
Age 67
Phone46 8 40 01 15 86
Webhttps://www.chordate.com

Chordate Medical Management Efficiency

The company has return on total asset (ROA) of (0.7129) % which means that it has lost $0.7129 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.6754) %, meaning that it generated substantial loss on money invested by shareholders. Chordate Medical's management efficiency ratios could be used to measure how well Chordate Medical manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

INSIDER Age

Julie RassatSinch AB
44
Henrik LarssonLyonHexatronic Group AB
57
Anna AhlbergSurgical Science Sweden
53
Beatrice ForsgrenEmbracer Group AB
N/A
Christian PriessHexatronic Group AB
53
Klemens KundratitzEmbracer Group AB
61
Jeffrey BerkleySurgical Science Sweden
54
Anton WestberghEmbracer Group AB
38
Oscar ErixonEmbracer Group AB
N/A
Magnus EideboHexatronic Group AB
48
AdvSurgical Science Sweden
55
Christina RaaschouSinch AB
46
Tomas JendelHexatronic Group AB
50
Marika DimmingSamhllsbyggnadsbolaget i Norden
N/A
Will ConwaySinch AB
38
Jonny GthbergSamhllsbyggnadsbolaget i Norden
N/A
EvaLotta StridhSamhllsbyggnadsbolaget i Norden
48
Lars WingeforsEmbracer Group AB
46
Adrian WestmanSamhllsbyggnadsbolaget i Norden
38
JiSun LundbomSamhllsbyggnadsbolaget i Norden
N/A
Ian GulamEmbracer Group AB
41
Chordate Medical Holding (CMH) is traded on Stockholm Exchange in Sweden and employs 3 people.

Management Performance

Chordate Medical Holding Leadership Team

Elected by the shareholders, the Chordate Medical's board of directors comprises two types of representatives: Chordate Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chordate. The board's role is to monitor Chordate Medical's management team and ensure that shareholders' interests are well served. Chordate Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chordate Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jan Hermansson, Head Director
Anders Weilandt, CEO MD
Jan Lindberg, CTO Mang
Niklas Lindecrantz, Chief Officer
Helena Thedius, Sales Mang

Chordate Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chordate Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Chordate Stock Analysis

When running Chordate Medical's price analysis, check to measure Chordate Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chordate Medical is operating at the current time. Most of Chordate Medical's value examination focuses on studying past and present price action to predict the probability of Chordate Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chordate Medical's price. Additionally, you may evaluate how the addition of Chordate Medical to your portfolios can decrease your overall portfolio volatility.